Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI)

Infection

Volumn 31, Issue 4, 2003, Pages 208-215

  Meyer, E ^a   Jonas, D ^a   Schwab, F ^b   Rueden, H ^b   Gastmeier, P ^c   Daschner, F D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; METICILLIN; OFLOXACIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; SULTAMICILLIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; DRUG SURVEILLANCE PROGRAM; DRUG USE; ESCHERICHIA COLI; GENOTYPE; GERMANY; HUMAN; INFECTION; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA;

EID: 0041352898     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-003-3201-7     Document Type: Article

References (33)

1. Barenfanger J, Short MA, Groesch AA: Improved antimicrobial interventions have benefits. J Clin Microbiol 2001; 39: 2823-2828.
2. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R: Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997; 24: 211-215.
3. Fridkin SK: Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 2001; 29(suppl 4): N64-8.
4. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, Gaynes RP, Tenover FC: Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999; 29: 245-252.
5. Harbarth S, Albrich W, Goldmann DA, Huebner J: Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis 2001; 1: 251-261.
6. Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE: A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8: 278-282.
7. Kresken M, Hafner D: Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975-1995. Study Group Bacterial Resistance of the Paul-Ehrlich-Society for Chemotherapy. Infection 1999; 27 (Suppl 2): 2-8.
8. Kresken M. Hafner D, Schmitz F-J, Wichelhaus T. für die Studiengruppe: Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen & Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahr 2001. Antiinfectives Intelligence. Bonn, 2003.
9. Kresken M, Hafner D: Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Chemotherapeutika in Mitteleuropa. Chemotherapie Joural 2000; 9: 51-86.
10. Albrich WC, Angstwurm M, Bader L, Gartner R: Drug resistance in intensive care units. Infection 1999; 27 (Suppl 2): 19-23.
11. Daschner F, Langmaack H, Wiedemann B: Antibiotic resistance in intensive care unit areas. Infect Control 1983; 4: 382-387.
12. Elliott TS, Lambert PA: Antibacterial resistance in the intensive care unit: mechanisms and management. Br Med Bull 1999; 55: 259-276.
13. Monnet DL: Toward multinational antimicrobial resistance surveillance systems in Europe. Int J Antimicrob Agents 2000; 15: 91-101.
14. Weinstein RA: Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis 2001; 7: 188-192.
15. Monnet DL, Sorensen TL: Interpreting the effectiveness of a national antibiotic policy and comparing antimicrobial use between countries. J Hosp Infect 1999; 43: 239-242.
16. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001; 29: 404-421.
17. Monnet DL, Archibald LK, Phillips L, Tenover FC, McGowan JE Jr, Gaynes RP: Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals. Infect Control Hosp Epidemiol 1998; 19: 388-394.
18. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically (4th edn). Approved Standard M7-A4. Wayne, PA, NCCLS, 1997.
19. DIN 58940-4 Medical microbiology - Methods for the determination of susceptibility of pathogens (except mycobacteria) to antimicrobial agents - part 4: Evaluation classes of the minimum inhibitory concentration. Beuth Verlag, Berlin 1998, pp 1-11.
20. Frank U, Jonas D, Lupke T, Ribeiro-Ayeh B, Schmidt-Eisenlohr E, Ruden H, Daschner FD: Antimicrobial susceptibility among nosocomial pathogens isolated in intensive care units in Germany. Eur J Clin Microbiol Infect Dis 2000; 19: 888-891.
21. Towner KJ, Talbot DC, Curran R, Webster CA, Humphreys H: Development and evaluation of a PCR-based immunoassay for the rapid detection of methicillin-resistant Staphylococcus aureus. J Med Microbiol 1998; 47: 607-613.
22. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
23. Winters MA, Goering RV, Boon SE, Morin R, Sorensen M, Snyder L: Epidemiological analysis of methicillin-resistant Staphylococcus aureus comparing plasmid typing with chromosomal analysis by field inversion gel electrophoresis. Med Microbiol Lett 1993; 2: 33-41.
24. Jonas D, Spitzmuller B, Weist K, Rueden H, Daschner F: Comparison of PCR-based methods for typing Escherichia coli. Clin Microbiol Infect 2003 (in press).
25. Speijer H, Savelkoul PH, Bonten MJ, Stobberingh EE, Tjhie JH: Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J Clin Microbiol 1999; 37: 3654-3661.
26. van der Zwet WC, Parlevliet GA, Savelkoul PH, Stoof J, Kaiser AM, Koeleman JG, Vandenbroucke-Grauls CM: Nosocomial outbreak of gentamicin-resistant Klebsiella pneumoniae in a neonatal intensive care unit controlled by a change in antibiotic policy. J Hosp Infect 1999; 42: 295-302.
27. Vos P, Hogers R, Bleeker M, Reijans M, van de Lee T, Hornes M, Frijters A, Pot J, Peleman J, Kuiper M: AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res 1995; 23: 4407-4414.
28. Proposal for a Council recommendation on the prudent use of antimicrobial agents in human medicine. Official Journal of the European Communities L 34/13, 13502-01. 2001.
29. Fridkin SK, Edwards JR, Courval JM, Hill H, Tenover FC, Lawton R, Gaynes RP, McGowan JE Jr: The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001; 135: 175-183.
30. Steward CD, Wallace D, Hubert SK, Lawton R, Fridkin SK, Gaynes RR McGowan JE Jr, Tenover FC: Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories. Diagn Microbiol Infect Dis 2000; 38: 59-67.
31. Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF: Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut. J Clin Microbiol 1999; 37: 4065-4070.
32. O'Neill GL, Murchan S, Gil-Setas A, Aucken HM: Identification and characterization of phage variants of a strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-15). J Clin Microbiol 2001; 39: 1540-1548.
33. Jonas D, Towner KJ, Loerwald M, Shunburne L, Schmidt-Wieland T, Daschner FD: Diversity of Staphylococcus aureus strains isolated from two European regions with different prevalences of methicillin resistance. Eur J Clin Microbiol Infect Dis 2002; 21: 880-883.